vs
Side-by-side financial comparison of Doximity, Inc. (DOCS) and CVR PARTNERS, LP (UAN). Click either name above to swap in a different company.
Doximity, Inc. is the larger business by last-quarter revenue ($185.1M vs $180.0M, roughly 1.0× CVR PARTNERS, LP). Doximity, Inc. runs the higher net margin — 33.3% vs 27.7%, a 5.5% gap on every dollar of revenue. On growth, CVR PARTNERS, LP posted the faster year-over-year revenue change (26.0% vs 9.8%). Over the past eight quarters, Doximity, Inc.'s revenue compounded faster (25.2% CAGR vs 16.4%).
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
CVR Partners, LP is a leading North American producer of nitrogen-based fertilizer products, primarily urea ammonium nitrate (UAN) and ammonia. It serves agricultural, industrial and commercial markets across the U.S. and Canada, delivering cost-effective, high-quality nutrient solutions for crop production and diverse industrial use cases.
DOCS vs UAN — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.1M | $180.0M |
| Net Profit | $61.6M | $49.9M |
| Gross Margin | 89.9% | 37.5% |
| Operating Margin | 38.9% | 32.0% |
| Net Margin | 33.3% | 27.7% |
| Revenue YoY | 9.8% | 26.0% |
| Net Profit YoY | -18.1% | 84.3% |
| EPS (diluted) | $0.31 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $180.0M | ||
| Q4 25 | $185.1M | $131.1M | ||
| Q3 25 | $168.5M | $163.5M | ||
| Q2 25 | $145.9M | $168.6M | ||
| Q1 25 | $138.3M | $142.9M | ||
| Q4 24 | $168.6M | $139.6M | ||
| Q3 24 | $136.8M | $125.2M | ||
| Q2 24 | $126.7M | $132.9M |
| Q1 26 | — | $49.9M | ||
| Q4 25 | $61.6M | $-10.3M | ||
| Q3 25 | $62.1M | $43.1M | ||
| Q2 25 | $53.3M | $38.8M | ||
| Q1 25 | $62.5M | $27.1M | ||
| Q4 24 | $75.2M | $18.3M | ||
| Q3 24 | $44.2M | $3.8M | ||
| Q2 24 | $41.4M | $26.2M |
| Q1 26 | — | 37.5% | ||
| Q4 25 | 89.9% | 4.4% | ||
| Q3 25 | 90.3% | 37.0% | ||
| Q2 25 | 89.2% | 32.4% | ||
| Q1 25 | 89.5% | 29.7% | ||
| Q4 24 | 91.6% | 23.8% | ||
| Q3 24 | 90.0% | 14.7% | ||
| Q2 24 | 89.3% | 30.0% |
| Q1 26 | — | 32.0% | ||
| Q4 25 | 38.9% | -2.2% | ||
| Q3 25 | 37.8% | 31.0% | ||
| Q2 25 | 37.4% | 27.5% | ||
| Q1 25 | 35.2% | 24.2% | ||
| Q4 24 | 47.4% | 18.4% | ||
| Q3 24 | 38.8% | 8.8% | ||
| Q2 24 | 36.4% | 25.3% |
| Q1 26 | — | 27.7% | ||
| Q4 25 | 33.3% | -7.8% | ||
| Q3 25 | 36.8% | 26.3% | ||
| Q2 25 | 36.5% | 23.0% | ||
| Q1 25 | 45.2% | 19.0% | ||
| Q4 24 | 44.6% | 13.1% | ||
| Q3 24 | 32.3% | 3.0% | ||
| Q2 24 | 32.7% | 19.7% |
| Q1 26 | — | — | ||
| Q4 25 | $0.31 | $-0.98 | ||
| Q3 25 | $0.31 | $4.08 | ||
| Q2 25 | $0.27 | $3.67 | ||
| Q1 25 | $0.31 | $2.56 | ||
| Q4 24 | $0.37 | $1.73 | ||
| Q3 24 | $0.22 | $0.36 | ||
| Q2 24 | $0.21 | $2.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.8M | $128.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $979.3M | — |
| Total Assets | $1.2B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $128.1M | ||
| Q4 25 | $64.8M | $69.2M | ||
| Q3 25 | $169.2M | $156.2M | ||
| Q2 25 | $137.3M | $114.4M | ||
| Q1 25 | $209.6M | $121.8M | ||
| Q4 24 | $165.3M | $90.9M | ||
| Q3 24 | $184.2M | $110.5M | ||
| Q2 24 | $111.4M | $47.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $569.1M | ||
| Q3 25 | — | $569.1M | ||
| Q2 25 | — | $569.2M | ||
| Q1 25 | — | $569.3M | ||
| Q4 24 | — | $568.0M | ||
| Q3 24 | — | $547.7M | ||
| Q2 24 | — | $547.6M |
| Q1 26 | — | — | ||
| Q4 25 | $979.3M | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $961.2M | — | ||
| Q2 24 | $913.6M | — |
| Q1 26 | — | $1.0B | ||
| Q4 25 | $1.2B | $969.5M | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.2B | $998.0M | ||
| Q1 25 | $1.3B | $1.0B | ||
| Q4 24 | $1.2B | $1.0B | ||
| Q3 24 | $1.1B | $986.6M | ||
| Q2 24 | $1.1B | $959.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.9M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 7.6% |
| Cash ConversionOCF / Net Profit | 0.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $60.9M | $-21.6M | ||
| Q3 25 | $93.9M | $91.7M | ||
| Q2 25 | $62.1M | $24.1M | ||
| Q1 25 | $98.5M | $55.4M | ||
| Q4 24 | $65.2M | $12.8M | ||
| Q3 24 | $68.3M | $86.7M | ||
| Q2 24 | $41.2M | $8.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-45.2M | ||
| Q3 25 | — | $80.1M | ||
| Q2 25 | — | $18.4M | ||
| Q1 25 | — | $45.5M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | — | $82.3M | ||
| Q2 24 | — | $2.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | -34.5% | ||
| Q3 25 | — | 49.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 31.9% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | — | 65.7% | ||
| Q2 24 | — | 1.8% |
| Q1 26 | — | 7.6% | ||
| Q4 25 | — | 18.0% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | 0.0% | 6.9% | ||
| Q4 24 | 0.0% | 13.1% | ||
| Q3 24 | 0.0% | 3.6% | ||
| Q2 24 | 0.0% | 4.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.99× | — | ||
| Q3 25 | 1.51× | 2.13× | ||
| Q2 25 | 1.16× | 0.62× | ||
| Q1 25 | 1.58× | 2.04× | ||
| Q4 24 | 0.87× | 0.70× | ||
| Q3 24 | 1.55× | 22.78× | ||
| Q2 24 | 1.00× | 0.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
UAN
| Fertilizer sales | $166.1M | 92% |
| Other | $14.0M | 8% |
